CompletedNot Applicable

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

Russia156 participantsStarted 2019-01-15

Plain-language summary

The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males and females aged 18-80 * Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI * Intra-arterial injection of iodinated contrast media * Informed consent Exclusion Criteria: * Age less than 18 * Pregnancy, lactation * Refuse to sign the informed consent * Contraindications for PCI * Other conditions affecting prognosis (oncology, liver failure etc) * CKD stage 4-5 * Patients receiving nephrotoxic drugs

What they're measuring

Contrast associated acute kidney injury

Timeframe: 48-72 hours

Trial details

NCT IDNCT04163484

SponsorI.M. Sechenov First Moscow State Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-30

View on ClinicalTrials.gov More Coronary Artery Disease trials